Vaccines show protective effects against rotavirus and pneumococcal disease in sub-Saharan African children
Vaccine Results Might Be Wrong Without These Factors
This systematic review and meta-analysis of 64 studies assessed vaccine effectiveness in children under five years in sub-Saharan Africa.
Vaccine studies in Africa often miss other health changes happening at the same time, which can make shots look more effective than they rea…
Elevated PCT and NLR identify pediatric IPD patients at higher risk for purulent meningitis
A Simple Blood Test Could Predict a Child's Meningitis Risk
This retrospective cohort study evaluated 56 pediatric patients with invasive pneumococcal disease (IPD) admitted to a hospital.
A simple blood test calculation helps doctors quickly identify children with dangerous infections who are at high risk for life-threatening …
ACIP Updates Recommendations for Pneumococcal Vaccine Use in U.S. Adults
Health Panel Updates Pneumococcal Vaccine Recommendations for U.S. Adults
The Advisory Committee on Immunization Practices (ACIP) has issued updated recommendations for pneumococcal vaccine use in U.S.
New U.S. guidelines now recommend specific pneumococcal vaccines for all adults aged 19 and older to protect against pneumonia and meningiti…
ACIP recommends 20-valent pneumococcal conjugate vaccine for children in the United States
Should your child get the new pneumococcal vaccine? Health advisors say yes
The Advisory Committee on Immunization Practices (ACIP) has updated its recommendations to include the 20-valent pneumococcal conjugate vacc…
A major U.S. health panel now recommends a new vaccine for children that guards against more strains of bacteria causing pneumonia and menin…
ACIP recommends 15-valent pneumococcal conjugate vaccine for U.S. children
What's the latest vaccine recommendation for protecting U.S. children from pneumococcal disease?
The Advisory Committee on Immunization Practices issued updated recommendations for using the 15-valent pneumococcal conjugate vaccine in U.…
Health officials updated 2022 vaccine guidance to include a new option protecting U.S. children against 15 strains of pneumococcal bacteria.
CDC Updates Pneumococcal Conjugate Vaccine Recommendation for Adults Aged 50+
Who should get the pneumonia vaccine? CDC updates recommendations for adults over 50
The CDC has updated its pneumococcal conjugate vaccine recommendation for adults aged 50 years or older who are PCV-naïve or have unknown va…
CDC now recommends the pneumonia vaccine for all adults over 50 who have never received it or don't know their vaccination history.
ACIP Recommends 21-Valent Pneumococcal Conjugate Vaccine as Option for Some U.S. Adults
U.S. health advisors recommend new pneumococcal vaccine option for adults
The Advisory Committee on Immunization Practices has issued a recommendation report for U.S.
U.S. health advisors now list a new 21-valent pneumococcal vaccine as an option for some adults to help prevent pneumonia and meningitis.
Questions about Pneumococcal Disease
Is the 21-valent pneumococcal conjugate vaccine an option for some U.S. adults?
The 21-valent pneumococcal conjugate vaccine is an approved option for some U.S. adults aged 19 and older who need protection against pneumococcal disease.
Full answer →Does the 15-valent pneumococcal conjugate vaccine work for U.S. children?
Yes, the 15-valent pneumococcal conjugate vaccine (PCV15) is recommended by the CDC for U.S. children aged 6 weeks to 17 years as an option for preventing pneumococcal disease.
Full answer →Which pneumococcal conjugate vaccine does ACIP recommend for U.S. children now?
The Advisory Committee on Immunization Practices (ACIP) currently recommends the 20-valent pneumococcal conjugate vaccine (PCV20) for children in the United States.
Full answer →Do vaccines protect against pneumococcal disease in sub-Saharan African children?
Research confirms that pneumococcal vaccines provide protective effects against the disease in children living in sub-Saharan Africa.
Full answer →